Akebia Therapeutics, Inc. (AKBA)
1.21
-0.15
(-11.03%)
USD |
NASDAQ |
Feb 13, 16:00
1.21
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics EPS Diluted (Quarterly) : 0.002 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 2.455 |
| Pfizer Inc. | -0.2898 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.54M |
| Revenue (Quarterly) | 58.77M |
| Total Expenses (Quarterly) | 58.23M |
| Enterprise Value | 366.25M |
| Gross Profit Margin (Quarterly) | 83.49% |
| Profit Margin (Quarterly) | 0.92% |
| Earnings Yield | -6.29% |
| Operating Earnings Yield | 5.83% |
| Normalized Earnings Yield | -4.702 |